Case reports and case series from Lancet had significant impact on medical literature

Journal of Clinical Epidemiology

Volumn 58, Issue 12, 2005, Pages 1227-1232

  Albrecht, Joerg ^a,d   Meves, Alexander ^b   Bigby, Michael ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MAYO CLINIC   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

Case reports; Case series; Clinical research; Clinical trials; Impact factor; Publication bias; Review

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; TIME SERIES ANALYSIS;

BIBLIOMETRICS; BIOMEDICAL RESEARCH; CASE-CONTROL STUDIES; HUMANS; MEDICAL RECORDS; PERIODICALS; PUBLICATION BIAS; RESEARCH DESIGN;

EID: 27744590464     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2005.04.003     Document Type: Article

References (32)

1. A.R. Feinstein, and R.I. Horwitz Problems in the "evidence" of "evidence-based medicine." Am J Med 103 1997 529 535
2. L.E. Moses The series of consecutive cases as a device for assessing outcomes of intervention N Engl J Med 311 1984 705 710
3. M. Jenicek Clinical case reporting in evidence-based medicine 2001 Arnold London
4. J.P. Vandenbroucke In defense of case reports and case series Ann Intern Med 134 2001 330 334
5. T. Greenhalgh, and R. Taylor Papers that go beyond numbers (qualitative research) BMJ 315 1997 740 743
6. S.W. Fraser, and T. Greenhalgh Coping with complexity: educating for capability BMJ 323 2001 799 803
7. T. Greenhalgh Integrating qualitative research into evidence based practice Endocrinol Metab Clin North Am 31 2002 583 601
8. A.H. Enk, and J. Knop Treatment of pemphigus vulgaris with mycophenolate mofetil Lancet 350 1997 494
9. U. Hohenleutner, V.D. Mohr, S. Michel, and M. Landthaler Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum Lancet 350 1997 1748
10. B. Zimmer-Molsberger, W. Knauf, and E. Thiel Mycophenolate mofetil for severe autoimmune haemolytic anemia Lancet 350 1997 1003 1004
11. R. Nowack, R. Birck, and F.J. van der Woude Mycophenolate mofetil for systemic vasculitis and IgA nephropathy Lancet 349 1997 774
12. M. Bohm, S. Beissert, T. Schwarz, D. Metze, and T. Luger Bullous pemphigoid treated with mycophenolate mofetil Lancet 349 1997 541
13. S. Conroy, I. Choonara, P. Impicciatore, A. Mohn, H. Arnell, and A. Rane Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children BMJ 320 2000 79 82
14. J.J. Gottlieb, K. Washenik, A. Chachoua, and A. Friedman-Kien Treatment of classic Kaposi's sarcoma with liposomal encapsulated doxorubicin Lancet 350 1997 1363 1364
15. A.F. Goddard, R.P. Logan, J.C. Atherton, D. Jenkins, and R.C. Spiller Healing of duodenal ulcer after eradication of Helicobacter heilmannii Lancet 349 1997 1815 1816
16. S. Vento, F. Cainelli, C. Renzini, G. Ghironzi, and E. Concia Resolution of autoimmune hepatitis after bone-marrow transplantation Lancet 348 1996 544 545
17. D.J. Joske, D.T. Ma, D.R. Langlands, and E.T. Owen Autologous bone-marrow transplantation for rheumatoid arthritis Lancet 350 1997 337 338
18. S.A. Brugger, C. Oesterreicher, H. Hofmann, P. Kalhs, H.T. Greinix, and C. Muller Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor Lancet 349 1997 996 997
19. G.K. Lau, R. Liang, C.K. Lee, and W.L. Lim Is vaccination of donor adequate for clearance of hepatitis B virus after bone-marrow transplantation? Lancet 349 1997 1626 1627
20. O. Ringden, B. Lonnqvist, and M. Holst 12-year follow-up of allogeneic bone-marrow transplant for Langerhans' cell histiocytosis Lancet 349 1997 476
21. R. Guleria, and J.N. Pande Endoscopic instillation of fungicide to treat aspergilloma Lancet 348 1996 621
22. N. Black Why we need observational studies to evaluate the effectiveness of health care BMJ 312 1996 1215 1218
23. J.M. Isner, A. Pieczek, R. Schainfeld, R. Blair, L. Haley, and T. Asahara Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb Lancet 348 1996 370 374
24. Quigley EM. Presentation of a manuscript and an abstract. OMGE, Train the trainers, workshop material, Crete, 4-28-2001.
25. K.S. Joseph Quality of impact factors of general medical journals BMJ 326 2003 283
26. K.S. Joseph, and J. Hoey CMAJ's impact factor: room for recalculation CMAJ 161 1999 977 978
27. R. Horton Medical editors trial amnesty Lancet 350 1997 756
28. R. Smith, and I. Roberts An amnesty for unpublished trials BMJ 315 1997 622
29. P.J. Easterbrook, J.A. Berlin, R. Gopalan, and D.R. Matthews Publication bias in clinical research Lancet 337 1991 867 872
30. U. Abel Bedeutung von Kasuistiken für die Wirksamkeitsü berprüfung medizinischer Therapien - meaning of case reports for testing the effectivness of medical therapy M.K.F.H. Bühring Naturheilverfahren und unkonventionelle Medizinische Richtungen - natural cures and uncoventional medical orientations 1998 Springer Berlin 1 12
31. U. Abel Erkenntnisgewinn mittels nichtrandomisierter Therapiestudien - gaining understanding through nonrandomised therapeutic studies Ellipse 15 1999 48 58
32. D. Moher, A. Jones, and L. Lepage Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation JAMA 285 2001 1992 1995